apyrase has been researched along with Hemangiosarcoma* in 1 studies
1 other study(ies) available for apyrase and Hemangiosarcoma
Article | Year |
---|---|
Comparison of immunosuppressive and cytotoxic cells in angiosarcoma: development of a possible supportive therapy for angiosarcoma.
An imbalance of immunosuppressive and cytotoxic cells plays an important role in inhibiting the anti-tumor immune response of the tumor-bearing host. The purpose of this study was to elucidate the involvement of immunosuppressive cells, such as regulatory T cells and CD163+ M2 macrophages as well as cytotoxic cells, such as granulysin-bearing cells and TIA-1+ cells in cutaneous angiosarcoma (AS) by immunohistochemical staining. In addition we evaluated the potencies of bisphosphonate, which was previously reported to suppress the expression of matrix metalloproteinase 9 (MMP-9), as a supportive therapy for AS together with docetaxel in 6 cases of cutaneous AS. These findings suggest that a high number of immunosuppressive cells might be related to the prognosis of AS, and that a combination of docetaxel with bisphosphonate risedronate sodium might be effective for MMP-9-expressing AS. Topics: Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Agents; Apyrase; Docetaxel; Drug Therapy, Combination; Enzyme Inhibitors; Etidronic Acid; Female; Forkhead Transcription Factors; Hemangiosarcoma; Humans; Macrophages; Male; Matrix Metalloproteinase 9; Poly(A)-Binding Proteins; Receptors, Cell Surface; Risedronic Acid; Skin Neoplasms; T-Cell Intracellular Antigen-1; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Taxoids | 2013 |